JPRN-UMIN000027243已完成未知
Anti-vascular endothelial growth factor therapy for ocular diseases of neovascularization - Anti-VEGF therapy for ocular neovascularization
School of Medicine Toho University0 个研究点目标入组 20 人开始时间: 2017年5月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1, high risk of stroke infarction 2, high risk of myocardial infarction 3, ocular infection
研究者
相似试验
招募中
1 期
Anti-vascular endothelial growth factor therapy for ocular diseases with neovascularizatiochoroidal neovascularization diabetic retinopathy retinal vein occulusion neovascular glaucoma retinopathy of prematurity central serous chorioretinopathyJPRN-UMIN000011094Kobe University Graduate school of Medicine510
已完成
不适用
Effect of anti-vascular endothelial growth factor (VEGF) drugs in chronic central serous chorioretinopathy (CSC)chronic central serous chorioretinopathyJPRN-UMIN000014110Kansai medical university takii hospital10
招募中
3 期
A clinical trial to study the levels of vascular endothelial growth factor in the fluid in the front part of the eye in cases of occlusion of venous supply of the eye and to correlate with the clinical features and nerve thickness as obtained by scanning and nerve function testsCTRI/2012/12/003270arayana Nethralaya30
招募中
不适用
Association of Vascular Endothelial Growth Factor (VEGF) serum levels And Ankylosing Spondylitis in Egyptian patientsAnkylosing spondylitisPACTR202210522771809Hossam salaheldin Abdelmohsen Labib70
招募中
不适用
Vascular Endothelial Growth Factor, thrombelastography and coagulation in the context of etiology, outcome and clinical course of patients after circulatory arrestI46Cardiac arrestDRKS00033234BG-Klinikum Unfallkrankenhaus Berlin150